Newborn umbilical cord, placenta stem cell storage, each family's "Yi" station -type Life Health Bank

In recent years, as an important branch in the field of biotechnology, stem cell research has promoted the rapid development of recycled medicine. It is another medical revolution after drug treatment and surgical treatment. From the perspective of stem cells, it has the ability to renew its ability and multi -directional differentiation. It is called "universal cells" by the medical community and is the core member of regeneration medicine. With the continuous progress of related technologies, the development of stem cell industrialization has made high progress, forming a perfect industrial chain covering upstream and downstream.

It is precisely because stem cells have taken the role of weightlifting in the field of biomedicine, and continue to attract the attention and attention of the state and local departments. During 2016-2022, a series of stem cell-related support policies were promulgated by the state and provinces and cities. From clinical research to industrial development, it has created a good environment for the development of the stem cell industry.

Among them, germinated stem cells between umbilical cords and placenta are important branches and components of the stem cell industry. The germinated stem cells in the umbilical cord and placenta have been regarded as treasures by scientists, and they are constantly showing their potential for prevention and anti -aging. According to relevant literature, there is a layer of gel -like gel -like gel -like gel -like gel -like gel -like gel in the umbilical vein in the neonatal cord tissue, called Huatong's gel. Stem cells are called germinated stem cells between umbilical cords.

(The picture comes from the online science science material)

With the advancement of medicine and technology, scientists have found that accommodation and cultivation from the umbilical cord can have the ability to repair and regenerate human tissue and organs, and is not troubled by medical ethics. All newborn umbilical cord tissue contains a lot of stem cells, making the collection simple and feasible. At the same time, in terms of storage, stem cells are easy to separate, high purity, and no pollution. The training system is unified during the expansion and facilitates quality control. It can be made into seed cell frozen and small cell loss.

To this day, thousands of clinical studies have been carried out globally in the world's umbilical cord and placenta, and the diseases that are treated are mostly multiple and difficult treatment at this stage, including arthritis, stroke, liver disease, diabetes, and diabetes. Cardiovascular disease, etc.

In terms of specific clinical research cases, the domestic three hospitals have carried out clinical research on the treatment of II diabetes in the treatment of cord cord germinated stem cell transplantation. Most patients have achieved the effect of decreased blood sugar and reduced insulin, and some patients even stop taking medication. In the treatment of 14 cases of osteoarthritis patients, such as Akgun, the Department of Estabel Department of Istanbul and the Department of Injury, found that patients with knee injury and orthopedic arthritis (KOOS) and visual simulation scores (VAS) were found to be treated in patients with germination stem cells. The improvement is more significant.

(The picture comes from the online science science material)

It is also the many advantages of the cord cord and placental stem cells that have made it "healthy cell empower" that has been cultivated in the industry for thirteen years in the industry.

With the strong support of governments at all levels and all sectors of society, Yiwenzai focuses on social needs and research and development of biotechnology featuring stem cells. Laboratory, Zhejiang Provincial Credit Cell Library, Integrated Cell Preparation Center in Zhejiang Provincial Regional Cell Preparation Center.

Among them, the medium -sized stem cell library between Zhejiang Province was approved in 2011. It has core technologies and international first -class standards, with stable and reliable quality, rigorous and transparent management. The Zhejiang Provincial Regional Cell Preparation Center has advanced cell preparation, storage and detection equipment, which mainly undertakes the work of cell product standards, cell collection and storage, cell preparation, cell quality management, etc. to effectively integrate industrial resources, promote the health and orderly industry of related industries develop.

The use of scientific and technological innovation and pouring time and full efforts to invest in cell drugs to develop and develop, obviously harvesting the fruit. And moving towards the high point of the industrial system. On the road of the cell health industry, it is willing to empower the health of more human beings.

Source: Zhonghua.com

- END -